The overexpression of galectin-9, which is known to suppress the adhesion of tumor cells to the extracellular matrix and vascular endothelium, could be advantageous for the treatment of squamous cell carcinomas because it limits the formation of metastases (50). The gene discussed is LGALS9; the disease is squamous cell carcinoma.